Berberine Sensitizes Human Ovarian Cancer Cells to Cisplatin Through miR-93/PTEN/Akt Signaling Pathway

Cellular Physiology and Biochemistry

Volumn 36, Issue 3, 2015, Pages 956-965

  Chen, Qiaoyun ^a   Qin, Rong ^a   Fang, Yue ^a   Li, Hao ^b  

^a AFFILIATED PEOPLE S HOSPITAL OF JIANGSU UNIVERSITY   (China)

^b TAIXING PEOPLE'S HOSPITAL   (China)

Author keywords

Berberine; Cisplatin; miR 93; Ovarian cancer cells

Indexed keywords

ANTIMITOTIC AGENT; BERBERINE; CISPLATIN; LUCIFERASE; MESSENGER RNA; MICRORNA; MICRORNA 93; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN KINASE B; TRICIRIBINE; UNCLASSIFIED DRUG; ANTINEOPLASTIC AGENT; MIRN93 MICRORNA, HUMAN; PTEN PROTEIN, HUMAN; RIBONUCLEOSIDE; SMALL INTERFERING RNA;

3' UNTRANSLATED REGION; ANTINEOPLASTIC ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; CANCER GROWTH; CANCER RESISTANCE; CELL PROLIFERATION; CELL SURVIVAL; CELL VIABILITY; CHEMOSENSITIZATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG MECHANISM; DRUG POTENTIATION; DRUG SCREENING; DRUG SENSITIZATION; ENZYME ACTIVITY; FEMALE; G1 PHASE CELL CYCLE CHECKPOINT; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IC50; OVARIAN CANCER CELL LINE; OVARY CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; WESTERN BLOTTING; AGONISTS; ANTAGONISTS AND INHIBITORS; DRUG EFFECTS; DRUG RESISTANCE; EPITHELIUM CELL; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; OVARY; PATHOLOGY; REPORTER GENE; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS; APOPTOSIS; BERBERINE; CELL LINE, TUMOR; CISPLATIN; DRUG RESISTANCE, NEOPLASM; DRUG SYNERGISM; EPITHELIAL CELLS; FEMALE; G1 PHASE CELL CYCLE CHECKPOINTS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, REPORTER; HUMANS; LUCIFERASES; MICRORNAS; OVARY; PROTO-ONCOGENE PROTEINS C-AKT; PTEN PHOSPHOHYDROLASE; RIBONUCLEOSIDES; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION;

EID: 84931827025     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000430270     Document Type: Article

References (33)

1. Ali AY, Farrand L, Kim JY, Byun S, Suh JY, Lee HJ, Tsang BK: Molecular determinants of ovarian cancer chemoresistance: new insights into an old conundrum. Ann N Y Acad Sci 2012;1271:58-67.
2. Harries M, Kaye SB: Recent advances in the treatment of epithelial ovarian cancer. Expert Opin Investig Drugs2001;10:1715-1724.
3. Li F, Guo Y, Han L, Duan Y, Fang F, Niu S, Ba Q, Zhu H, Kong F, Lin C, Wen X: In vitro and in vivo growth inhibition of drug-resistant ovarian carcinoma cells using a combination of cisplatin and a TRAlL-encoding retrovirus. Oncol Lett 2012;4:1254-1258.
4. Jantova S, Cipak L, Cernakova M, Kost'alova D: Effect of berberine on proliferation, cell cycle and apoptosis in HeLa and L1210 cells. J Pharm Pharmacol 2003;55:1143-1149.
5. Lin JP, Yang JS, Lee JH, Hsieh WT, Chung JG: Berberine induces cell cycle arrest and apoptosis in human gastric carcinoma SNU-5 cell line. World J Gastroenterol 2006;12:21-28.
6. Hwang JM, Kuo HC, Tseng TH, Liu JY, Chu CY: Berberine induces apoptosis through a mitochondria/ caspases pathway in human hepatoma cells. Arch Toxicol 2006;80:62-73.
7. Lin CC, Yang JS, Chen JT, Fan S, Yu FS, Yang JL, Lu CC, Kao MC, Huang AC, Lu HF, Chung JG: Berberine induces apoptosis in human HSC-3 oral cancer cells via simultaneous activation of the death receptor-mediated and mitochondrial pathway. Anticancer Res 2007;27:3371-3378.
8. Mantena SK, Sharma SD, Katiyar SK: Berberine, a natural product, induces Gl-phase cell cycle arrest and caspase-3-dependent apoptosis in human prostate carcinoma cells. Mol Cancer Ther 2006;5:296-308.
9. Lin CC, Lin SY, Chung JG, Lin JP, Chen GW, Kao ST: Down-regulation of cyclin Bl and up-regulation ofWeel by berberine promotes entry ofleukemia cells into the G2/M-phase of the cell cycle. Anticancer Res 2006;26:1097-1104.
10. Liu Z, Liu Q, Xu B, Wu J, Guo C, Zhu F, Yang Q, Gao G, Gong Y, Shao C: Berberine induces p53-dependent cell cycle arrest and apoptosis ofhuman osteosarcoma cells by inflicting DNA damage. Mutat Res 2009;662:75-83.
11. Sanders MM, Liu AA, Li TK, Wu HY, Desai SD, Mao Y, Rubin EH, LaVoie EJ, Makhey D, Liu LF: Selective cytotoxicity of topoisomerase-directed protoberberines against glioblastoma cells. Biochem Pharmacol 1998;56:1157-1166.
12. Park KS, Kim JB, Lee SJ, Bae J: Berberine-induced growth inhibition of epithelial ovarian carcinoma cell lines. J Obstet Gynaecol Res 2012;38:535-540.
13. Lin S, Tsai SC, Lee CC, Wang BW, Liou JY, Shyu KG: Berberine inhibits HIF-lalpha expression via enhanced proteolysis. Mol Pharmacol 2004;66:612-619.
14. Peng PL, Kuo WH, Tseng HC, Chou FP: Synergistic tumor-killing effect of radiation and berberine combined treatment in lung cancer: the contribution of autophagic cell death. Int J Radiat Oncol Biol Phys 2008;70:529-542.
15. Tong N, Zhang J, Chen Y, Li Z, Luo Y, Zuo H, Zhao X: Berberine sensitizes mutliple human cancer cells to the anticancer effects of doxorubicin invitro. Oncol Lett 2012;3:1263-1267.
16. Fu X, Tian J, Zhang L, Chen Y, Hao Q: Involvement of microRNA-93, a new regulator of PTEN/Akt signaling pathway, in regulation of chemotherapeutic drug cisplatin chemosensitivity in ovarian cancer cells. FEBS Lett2012;586:1279-1286.
17. Basu A, Teicher BA, Lazo JS: Involvement of protein kinase C in phorbol ester-induced sensitization of HeLa cells to cis-diamminedichloroplatinum(II). J Biol Chem 1990;265:8451-8457.
18. Chen C, Ridzon DA, Broomer AJ, Zhou Z, Lee DH, Nguyen JT, Barbisin M, Xu NL, Mahuvakar VR, Andersen MR, Lao KQ, Livak KJ, Guegler KJ: Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic Acids Res 2005;33:el79.
19. Singh B, Ronghe AM, Chatterjee A, Bhat NK, Bhat HK: MicroRNA-93 regulates NRF2 expression and is associated with breast carcinogenesis. Carcinogenesis 2013;34:1165-1172.
20. Rabik CA, Dolan ME: Molecular mechanisms of resistance and toxicityassociated with platinating agents. Cancer Treat Rev 2007;33:9-23.
21. Johnstone RW, Ruefli AA, Lowe SW: Apoptosis: a link between cancer genetics and chemotherapy. Cell 2002;108:153-164.
22. Sorrentino A, Liu CG, Addario A, Peschle C, Scambia G, Ferlini C: Role of microRNAs in drug-resistant ovarian cancer cells. Gynecol Oncol 2008;111:478-486.
23. Solar P, Sytkowski AJ: Differentially expressed genes associated with cisplatin resistance in human ovarian adenocarcinoma cell line A2780. Cancer Lett 2011;309:11-18.
24. ZimmermanAL, Wu S: MicroRNAs, cancer and cancer stem cells. Cancer Lett 2011;300:10-19.
25. Hummel R, Hussey DJ, Haier J: MicroRNAs: predictors and modifiers of chemo-and radiotherapy in differenttumour types. Eur J Cancer 2010;46:298-311.
26. Yu ZW, Zhong LP, Ji T, Zhang P, Chen WT, Zhang CP: MicroRNAs contribute to the chemoresistance of cisplatin intongue squamous cell carcinoma lines. Oral Oncol 2010;46:317-322.
27. Hummel R, Watson DI, Smith C, Kist J, Michael MZ, Haier J, Hussey DJ: Mir-148a improves response to chemotherapy in sensitive and resistant oesophageal adenocarcinoma and squamous cell carcinoma cells. J Gastrointest Surg 2011;15:429-438.
28. Imanaka Y, Tsuchiya S, Sato F, Shimada Y, Shimizu K, Tsujimoto G: MicroRNA-141 confers resistance to cisplatin-induced apoptosis by targeting YAP1 in human esophageal squamous cell carcinoma. J Hum Genet 2011;56:270-276.
29. Li Y, Zhu X, Gu J, Dong D, Yao J, Lin C, Huang K, Fei J: Anti-miR-21 oligonucleotide sensitizes leukemic K562 cells to arsenic trioxide by inducing apoptosis. Cancer Sci 2010;101:948-954.
30. Zhou M, Gu L, Findley HW, Jiang R, Woods WG: PTEN reverses MDM2-mediated chemotherapy resistance by interacting with p53 in acute lymphoblastic leukemia cells. Cancer Res 2003;63:6357-6362.
31. Testa JR, Bellacosa A: AKT plays a central role in tumorigenesis. Proc Natl Acad SciUSA 2001;98:10983-10985.
32. Yuan Z, Wang F, Zhao Z, Zhao X, Qiu J, Nie C, Wei Y: BIM-mediated AKT phosphorylation is a key modulator of arsenic trioxide-induced apoptosis in cisplatin-sensitive and-resistant ovarian cancer cells. PLoS One 2011;6:e20586.
33. Yang H, Kong W, He L, Zhao JJ, O'Donnell JD, Wang J, Wenham RM, Coppola D, Kruk PA, Nicosia SV, Cheng JQ: MicroRNA expression profiling in human ovarian cancer: miR-214 induces cell survival and cisplatin resistance bytargeting PTEN. Cancer Res 2008;68:425-433.